ChiCTR注册号: Reg No. in ChiCTR: |
ChiCTR2000036350 | ||||||||||||||||||||||
研究题目: |
评价靶向CD19/CD20/CD22/CD33/CD123/CLL-1/ CD138/BCMA/ CD30等细胞表面生物标志物的抗原受体工程化T细胞免疫治疗技术(CART)治疗带有相应生物标志物阳性的血液系统恶性肿瘤的安全性及有效性的非盲、无对照、单中心的初步临床研究 |
||||||||||||||||||||||
Study title: |
An unblinded, uncontrolled, single-center preliminary clinical study to evaluate the safety and efficacy of chimeric antigen-receptor engineered T cell immunotherapy (CART) targeting CD19/CD20/CD22/CD33/CD123/CLL-1/ CD138/BCMA/ CD30 and other cell surface biomarkers in the treatment of hematologic malignancies with positive corresponding biom |
||||||||||||||||||||||
注册状况: Registration: |
False |
||||||||||||||||||||||
注册机构: |
中国临床试验注册中心 |
||||||||||||||||||||||
Name of the Registry: |
Chinese Clinical Trial Registry |
||||||||||||||||||||||
项目负责人: |
李昕 |
||||||||||||||||||||||
Corresponding person: |
Li Xin |
||||||||||||||||||||||
电话: Telephone: |
13808418932 | ||||||||||||||||||||||
电子邮件 |
lixiner1975@163.com |
||||||||||||||||||||||
通讯地址: |
湖南省长沙市岳麓区中南大学湘雅三医院 |
||||||||||||||||||||||
Address: |
The Third Xiangya Hospital,Central South University, Yuelu District, Changsha city, Hunan Province, China |
||||||||||||||||||||||
邮政编码 Postcode |
410000 |
||||||||||||||||||||||
项目负责人所有单位: |
中南大学湘雅三医院 |
||||||||||||||||||||||
Institution: |
The Third Xiangya Hospital of Central South Univer |
||||||||||||||||||||||
批准本研究的伦理委员会名称: |
中南大学湘雅三医院伦理委员会 |
||||||||||||||||||||||
Name of the ethic committee: |
Ethics Committee of The Third Xiangya Hospital of |
||||||||||||||||||||||
研究疾病: |
血液恶性肿瘤 | ||||||||||||||||||||||
Study Ailment: |
Hematologic malignancy | ||||||||||||||||||||||
研究所处阶段: Study phase: |
上市前 | ||||||||||||||||||||||
研究类型: Type of Study: |
治疗研究 | ||||||||||||||||||||||
研究团队: |
李昕、成倩、唐亦舒、肖晗、张芳荣、陈欣、张畅、刘蕊、方丹、鲁林丽 |
||||||||||||||||||||||
Research team: |
Li Xin、Cheng Qian、Tang Yishu、Xiao Han、Zhang Fangrong、Chen Xin、Zhang Chang、Liu Rui、Fang Dan、Lu Linli |
||||||||||||||||||||||
研究实施地点: Site of Study: |
|
||||||||||||||||||||||
预计起止时间: Planned Duration: |
2016/6/23 0:00:00-2020/12/31 0:00:00 |